DekaBank Deutsche Girozentrale’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,100	Closed	-$115K	–	1240
2017 Q4	$115K	Hold	11,100	–	–	﹤0.01%	979
2017 Q3	$115K	Hold	11,100	–	–	﹤0.01%	985
2017 Q2	$118K	Hold	11,100	–	–	﹤0.01%	962
2017 Q1	$123K	Sell	11,100 -900	-8%	-$10.4K	﹤0.01%	887
2016 Q4	$162K	Buy	+12,000	New	+$167K	﹤0.01%	859
2016 Q2	–	Sell	-19,500	Closed	-$202K	–	1084
2016 Q1	$202K	Sell	19,500 -3,500	-15%	-$44.2K	﹤0.01%	847
2015 Q4	$407K	Buy	23,000 +300	+1%	+$5.38K	﹤0.01%	728
2015 Q3	$451K	Buy	22,700 +900	+4%	+$20.6K	0.01%	714
2015 Q2	$358K	Buy	21,800 +800	+4%	+$13.9K	﹤0.01%	772
2015 Q1	$327K	Sell	21,000 -2,700	-11%	-$41.9K	﹤0.01%	808
2014 Q4	$329K	Sell	23,700 -2,300	-9%	-$24.3K	﹤0.01%	781
2014 Q3	$169K	Buy	26,000 +500	+2%	+$3.32K	﹤0.01%	844
2014 Q2	$176K	Sell	25,500 -1,000	-4%	-$7.07K	﹤0.01%	767
2014 Q1	$189K	Buy	26,500 +2,500	+10%	+$21.4K	﹤0.01%	726
2013 Q4	$227K	Buy	24,000 +500	+2%	+$3.57K	﹤0.01%	652
2013 Q3	$147K	Buy	23,500 +2,000	+9%	+$12.5K	﹤0.01%	700
2013 Q2	$146K	Buy	+21,500	New	+$171K	﹤0.01%	567

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

DekaBank Deutsche Girozentrale's SCMP Position: Q1 2018 in Review

DekaBank Deutsche Girozentrale sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 11,100 shares — an estimated $115K sold.

DekaBank Deutsche Girozentrale first reported a position in SCMP in Q2 2013 and held it in 17 quarters. The position peaked at $451K in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

DekaBank Deutsche Girozentrale reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 11,100 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $115K.
DekaBank Deutsche Girozentrale first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
DekaBank Deutsche Girozentrale's Sucampo Pharmaceuticals, Inc. position peaked at $451K in Q3 2015.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2018, filed 3 May 2018.